发明名称 |
Methods of treating a cancer using substituted pyrrolopyrimidine compounds, compositions thereof |
摘要 |
Provided herein are methods for treating or preventing a cancer, in particular solid tumors and hematological cancers, comprising administering to a subject in need thereof an effective amount of a compound of formula (I):; |
申请公布号 |
US9623028(B2) |
申请公布日期 |
2017.04.18 |
申请号 |
US201514797548 |
申请日期 |
2015.07.13 |
申请人 |
Signal Pharmaceuticals, LLC |
发明人 |
Zhu Dan;Boylan John;Xu Shuichan;Riggs Jennifer;Shi Tao;Wurmser Andrew;Mikolon David;Deyanat-Yazdi Gordafaried |
分类号 |
A61K31/519;A61K31/437;A61K31/5377;A61K31/635;A61K31/00 |
主分类号 |
A61K31/519 |
代理机构 |
Jones Day |
代理人 |
Jones Day |
主权项 |
1. A method for treating glioblastoma multiforme, comprising administering to a subject having glioblastoma multiforme an effective amount of Pyrrolopyrimidine Compound, wherein the Pyrrolopyrimidine Compound is a compound of formula (I): and pharmaceutically acceptable salts, tautomers, stereoisomers, enantiomers, and isotopologues thereof, wherein: R1 is substituted or unsubstituted C1-8 alkyl, substituted or unsubstituted C3-8 cycloalkyl, or substituted or unsubstituted non-aromatic heterocyclyl; R2 is substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl; R3 is substituted or unsubstituted heterocyclyl or substituted or unsubstituted aryl, and L is NH or O; provided R3 is not pyridyl when L is NH or when R2 is pyrazolyl; and the compound is not N-methyl-N-[trans-3-[[5-(1-methyl-1H-pyrazol-4-yl)-2-[(1-methyl-1H-pyrazol-4-yl)amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]oxy]cyclobutyl]-2-propenamide; or N-methyl-N-[trans-3-[[5-(1-methyl-1H-pyrazol-3-yl)-2-[(1-methyl-1H-pyrazol-4-yl)amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]oxy]cyclobutyl]-2-propenamide. |
地址 |
San Diego CA US |